ImmuCell VP awarded 5,000 stock options
ImmuCell Corp. vice president Bobbi Jo Brockmann received a grant of 5,000 incentive stock options for company common stock.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Form Type
4
Rhea-AI Filing Summary
ImmuCell Corp. vice president Bobbi Jo Brockmann received a grant of 5,000 incentive stock options for company common stock. The options carry an exercise price of $5.49 per share and relate to 5,000 underlying common shares. They are reported as directly owned and expire on April 16, 2030.
Insider Trade Summary
Grant/Award: 5,000 shares
Grant/Award
1 txn
Insider
Brockmann Bobbi Jo
Role
VP of Sales and Marketing
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Incentive Stock Options (Right to buy) | 5,000 | $0.00 | $0.00 |
Holdings After Transaction:
Incentive Stock Options (Right to buy) — 5,000 contracts (Direct)
Key Figures
Options granted: 5,000 options
Exercise price: $5.49 per share
Underlying shares: 5,000 shares
+2 more
5 metrics
Options granted
5,000 options
Incentive stock options awarded to VP Bobbi Jo Brockmann
Exercise price
$5.49 per share
Price to buy ImmuCell common stock under options
Underlying shares
5,000 shares
Common stock underlying the incentive stock options
Expiration date
April 16, 2030
Date on which unexercised options lapse
Total options after grant
5,000 options
Total derivative holdings reported following this transaction
Key Terms
Incentive Stock Options, Form 4, exercise price, underlying security, +1 more
5 terms
Incentive Stock Options financial
"Incentive Stock Options (Right to buy)"
Incentive stock options are a type of employee stock option that gives eligible workers the right to buy company shares at a fixed price later on, often below future market value. They matter to investors because they align employee incentives with company performance, can dilute existing ownership when exercised, and create potential tax advantages for option holders if certain holding-time rules are met — think of them as a coupon to buy stock at today’s price with extra tax rules attached.
Form 4 regulatory
"INSIDER FILING DATA (Form 4):"
Form 4 is a official document that company insiders, such as executives or major shareholders, file with regulators whenever they buy or sell company shares. It provides transparency about how those with inside knowledge are trading, helping investors see if insiders are confident in the company's prospects or may be selling for personal reasons. This information can influence investor decisions by revealing insiders' perspectives on the company's value.
exercise price financial
"conversion_or_exercise_price": "5.4900""
The exercise price is the fixed amount at which you can buy or sell an asset, like a stock, when using an options contract. It matters because it helps determine whether exercising the option will be profitable or not, depending on the current market price. Think of it as the set price you agree on today to buy or sell later.
underlying security financial
"underlying_security_title": "Common Stock""
expiration date financial
"expiration_date": "2030-04-16T00:00:00.000Z""
The expiration date is the deadline after which a financial contract, such as an option or a futures agreement, is no longer valid or can be exercised. It matters to investors because it determines the timeframe during which they can take action or benefit from the contract, similar to how a coupon or a food item has a limited period of usefulness. Once the expiration date passes, the contract loses its value or ability to be used.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did ImmuCell (ICCC) executive Bobbi Jo Brockmann report on this Form 4?
Bobbi Jo Brockmann reported receiving 5,000 incentive stock options for ImmuCell common stock. These are compensation-related options, not an open-market share purchase, and give her the right to buy 5,000 shares at a preset exercise price.
How many ImmuCell (ICCC) stock options were granted to Bobbi Jo Brockmann?
She was granted 5,000 incentive stock options. Each option represents the right to acquire one share of ImmuCell common stock, so the award covers 5,000 underlying shares if the options are eventually exercised.
What is the exercise price of Bobbi Jo Brockmann’s ImmuCell (ICCC) stock options?
The options have an exercise price of $5.49 per share. This means she can buy ImmuCell common stock at $5.49 for each option exercised, regardless of the market price at exercise time.
When do Bobbi Jo Brockmann’s ImmuCell (ICCC) options expire?
The incentive stock options expire on April 16, 2030. After that expiration date, any unexercised options will lapse and no longer give her the right to purchase ImmuCell common shares.
Is Bobbi Jo Brockmann’s ImmuCell (ICCC) Form 4 a stock purchase or a grant?
The Form 4 reports a grant of options, not a stock purchase. She received 5,000 incentive stock options as an award, giving her a future right to buy shares at $5.49, rather than buying shares in the market now.
AI-generated analysis. How Rhea-AI works. Not financial advice.
Accepted by SEC EDGAR
Learn about SEC filing dates